Codelivery of triptolide and IFN-γ to boost antitumor immunity for triple-negative breast cancer-Reference-Cited by-同舟云学术

Codelivery of triptolide and IFN-γ to boost antitumor immunity for triple-negative breast cancer

Published:2023-07 Issue: Volume:120 Page:110346
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Cai Jianya^ORCID,Zhong Minjie^ORCID,Xu Jianhua^ORCID,Cheng Hongwei^ORCID,Xu Shuangta

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Triple-negative breast cancer therapeutic resistance: Where is the achilles' heel?;Bai;Cancer letters,2021

2. Breast Cancer Immunotherapy: Facts and hopes, clinical cancer research : An official journal of the american association for;Emens;Cancer Research,2018

3. Breast cancer screening trials: Endpoints and overdiagnosis;Jatoi;Journal of the National Cancer Institute,2021

4. Screening for breast cancer in average-risk women: A guidance statement from the American college of physicians;Qaseem;Annals of internal medicine,2019

5. The landscape of targeted therapies in TNBC;Vagia;Cancers,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a CD8+ T cells‐related prognostic risk model for acral melanoma based on single‐cell and bulk RNA sequencing;Skin Research and Technology;2024-08

2. Advanced Hydrogels in Breast Cancer Therapy;Gels;2024-07-19

3. Exosomal transfer of HCC-derived miR-17-5p downregulates NK cell function by targeting RUNX1-NKG2D axis;International Immunopharmacology;2024-07

4. TGF β1 promotes the polarization of M2-type macrophages and activates PI3K/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin;International Immunopharmacology;2024-06

5. A dual-functional oncolytic adenovirus ZD55-aPD-L1 scFv armed with PD-L1 inhibitor potentiates its antitumor activity;International Immunopharmacology;2024-02